Cellectar reports financial results for the first quarter 2021 and provides a corporate update

Initiated pivotal study of clr 131 in waldenstrom's macroglobulinemia (wm) received european orphan drug designation for clr 131 in wm
CLRB Ratings Summary
CLRB Quant Ranking